Paresthesia as a favorable predictor of migraine prophylaxis using topiramate

European Journal of Neurology

Volumn 14, Issue 6, 2007, Pages 654-658

  Lee, S T ^a   Chu, K ^a   Park, J E ^a   Park, H J ^a   Park, J H ^a   Lee, S H ^a   Kim, M ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

Carbonic anhydrase; Migraine; Paresthesia; Topiramate

Indexed keywords

TOPIRAMATE;

ADULT; AGED; ANALYTICAL ERROR; ARTICLE; CHEMOPROPHYLAXIS; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DECREASED APPETITE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG WITHDRAWAL; FATIGUE; FEMALE; HEADACHE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MIGRAINE; NAUSEA; OPEN STUDY; PARESTHESIA; PREDICTION; PRIORITY JOURNAL; SCREENING; SIDE EFFECT; SURVIVAL; TASTE DISORDER; TREATMENT RESPONSE; WEIGHT REDUCTION;

ADULT; AGED; ANTICONVULSANTS; FEMALE; FRUCTOSE; HEADACHE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PARESTHESIA; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 34249787360     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2007.01804.x     Document Type: Article

References (15)

1. Silberstein SD, Neto W, Schmitt J, Jacobs D, for the MIGR-001 Study Group. Topiramate in migraine prevention: results of a large, controlled trial. Archives of Neurology 2004 61 : 490 495.
2. Brandes JL, Saper JR, Diamond M, et al. MIGR-002 Study Group. Topiramate for migraine prevention: a randomized controlled trial. The Journal of the American Medical Association 2004 291 : 965 973.
3. Diener HC, Tfelt-Hansen P, Dahlof C, et al. MIGR-003 Study Group. Topiramate in migraine prophylaxis-results from a placebo-controlled trial with propranolol as an active control. Journal of Neurology 2004 251 : 943 950.
4. White HS. Molecular pharmacology of topiramate: managing seizures and preventing migraine. Headache 2005 45 : S48 S56.
5. D'Amico D, Grazzi L, Usai S, Moschiano F, Bussone G. Topiramate in migraine prophylaxis. Neurological Sciences 2005 26 : S130 S133.
6. Silberstein SD. Topiramate in migraine prevention. Headache 2005 45 : S57 S65.
7. Brandes JL. Practical use of topiramate for migraine prevention. Headache 2005 45 : S66 S73.
8. Dodgson SJ, Shank RP, Maryanoff BE. Topiramate as an inhibitor of carbonic anhydrase isoenzymes. Epilepsia 2000 41 : S35 S39.
9. Lee J, Taira T, Pihlaja P, Ransom BR, Kaila K. Effects of CO2 on excitatory transmission apparently caused by changes in intracellular pH in the rat hippocampal slice. Brain Research 1996 706 : 210 216.
10. Herrero AI, Del Olmo N, Gonzalez-Escalada JR, Solis JM. Two new actions of topiramate: inhibition of depolarizing GABA(A)-mediated responses and activation of a potassium conductance. Neuropharmacology 2002 42 : 210 220.
11. Haan J, Sluis P, Sluis LH, Ferrari MD. Acetazolamide treatment for migraine aura status. Neurology 2000 55 : 1588 1589.
12. De Simone R, Marano E, Di Stasio E, et al. Acetazolamide efficacy and tolerability in migraine with aura: a pilot study. Headache 2005 45 : 385 386.
13. Vahedi K, Taupin P, Djomby R, et al. DIAMIG investigators. Efficacy and tolerability of acetazolamide in migraine prophylaxis: a randomised placebo-controlled trial. Journal of Neurology 2002 249 : 206 211.
14. Moscucci M, Byrne L, Weintraub M, Cox C. Blinding, unblinding, and the placebo effect: an analysis of patients' guesses of treatment assignment in a double-blind clinical trial. Clinical Pharmacology and Therapeutics 1987 41 : 259 265.
15. Tfelt-Hansen P, Block G, Dahlof C, et al. Guidelines for controlled trials for drugs in migraine: second edition. Cephalalgia 2000 20 : 765 786.